GSA Capital Partners’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
GSA Capital Partners's ABMD Position: Q4 2022 in Review
GSA Capital Partners sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,681 shares — an estimated $904K sold.
GSA Capital Partners first reported a position in ABMD in Q3 2013 and held it in 21 quarters. The position peaked at $3.69M in Q1 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- GSA Capital Partners reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- GSA Capital Partners sold 3,681 Abiomed Inc shares in Q4 2022, an estimated $904K.
- GSA Capital Partners first reported a position in Abiomed Inc in Q3 2013 and held it in 21 quarters.
- GSA Capital Partners's Abiomed Inc position peaked at $3.69M in Q1 2019.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on GSA Capital Partners's 13F filing for Q4 2022, filed 13 Feb 2023.